Cargando…
Letter to the editor: is it valid to break down results from long-term trials in bipolar disorder by polarity of relapses?
When analysing and reporting data from long-term drug trials in bipolar disorder, it has become the standard to break down the outcome into the prevention of mania and the prevention of depression. However, as illustrated by a theoretical example, this approach may confer a potential analysis bias....
Autores principales: | Licht, Rasmus Wentzer, Severus, Emanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452634/ https://www.ncbi.nlm.nih.gov/pubmed/26092395 http://dx.doi.org/10.1186/s40345-014-0008-7 |
Ejemplares similares
-
Diagnosing bipolar disorders in DSM-5
por: Severus, Emanuel, et al.
Publicado: (2013) -
Letter to the Editor
por: Tolstrup Larsen, Rasmus
Publicado: (2018) -
The impact of treatment decisions on the diagnosis of bipolar disorders
por: Severus, Emanuel, et al.
Publicado: (2014) -
Diagnosing bipolar disorders: ICD-11 and beyond
por: Severus, Emanuel, et al.
Publicado: (2020) -
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
por: Ellegaard, Pernille Kempel, et al.
Publicado: (2018)